New studies continue to show safety and effectiveness of GLP-1 drugs March 17, 2026 Summary: Several recent studies highlight the effectiveness and safety of GLP-1 medications for treating obesity and diabetes, and one study shows better adherence than previously reported
It's unclear how they'll weigh the findings of the career scientists at the FDA who state there's insufficient evidence to support changing the designation for any of the seven peptides under consideration
The mixture was lyophilized to yield a white solid containing diketopiperazine (DKP) as well as oxidized and reduced forms of DTT
They also suggested that the natriuretic effect of GLP-1 RAs they have seen in their study might be one of the mechanisms behind the BP-lowering effect of GLP-1 RAs, although the BP reduction was not significant in their study [39]
Until then, we must be cautious
For research sourcing, The Peptide Guide highlights AminoVault as an option